RxDoctor Payments Data

James Newton, MD

Interventional Pain Medicine · Columbia, MONPI 1902871361

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $5,957 of the $7,263 with a category attached, or 82.0%. Abbott accounts for 67.3% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2019 at $2,043 and has fallen 67.5% since, to $665 in 2025.

$7,263in general payments, 2019–2025

Across 266 payments — averaging $27.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$5K
  • Boston Scientific$2K
  • Medtronic$218
  • Pacira Therapeutics, Inc.$95
  • Vertos Medical, Inc.$81
  • Nalu Medical, Inc.$70
  • plus $194 from 8 others

What the payments were for

  • Travel & lodging$1,30618%
  • Food & beverage$5,95782%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,263 in reported general payments places this provider in the 65th percentile of 27 interventional pain medicine providers in Missouri.

See all interventional pain medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$650,796
Medicare patients
994
Services billed
17,566

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Pregabalin850$24,567
Gabapentin803$12,361
Buprenorphine40$9,330
Duloxetine Hcl555$8,635
Baclofen528$6,297
Methocarbamol331$4,054
Acetaminophen-CodeineAcetaminophen With Codeine162$1,569
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen135$1,461
Tramadol Hcl295$1,053
Tizanidine Hcl116$968
Chlorzoxazone17$661
Celecoxib20$497
Nortriptyline Hcl44$465
Meloxicam125$444
Diclofenac Sodium28$429

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Columbia

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →